GeneDx Holdings Corp. Cost of Revenue
GeneDx Holdings Corp. (WGS) reported Cost of Revenue of $36.20 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-03
- GeneDx Holdings Corp. cost of goods and services sold for the quarter ending 2026-06-30 was $36.20M, a 13.88% increase year-over-year.
- GeneDx Holdings Corp. cost of goods and services sold for the quarter ending 2026-03-31 was $34.04M, a 18.87% increase year-over-year.
- GeneDx Holdings Corp. cost of goods and services sold for the quarter ending 2025-12-31 was $36.72M, a 24.75% increase year-over-year.
- GeneDx Holdings Corp. cost of goods and services sold for the quarter ending 2025-09-30 was $32.22M, a 10.92% increase year-over-year.
- GeneDx Holdings Corp. cost of goods and services sold for fiscal 2025 was $129.37M, a 16.49% increase from fiscal 2024.
- GeneDx Holdings Corp. cost of goods and services sold for fiscal 2024 was $111.05M, a 1.34% decline from fiscal 2023.
- GeneDx Holdings Corp. cost of goods and services sold for fiscal 2023 was $112.56M, a 56.95% decline from fiscal 2022.
- GeneDx Holdings Corp. cost of goods and services sold for fiscal 2022 was $261.44M, a 14.27% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 3 month as first filed | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 9 month as first filed | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $36.20M 10-Q · filed 2026-08-03 | $70.25M 10-Q · filed 2026-08-03 | $106.97M derived: sum of 3 quarters · filed 2026-08-03 | $139.18M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2026-03-31 | $34.04M 10-Q · filed 2026-05-04 | $70.76M derived: sum of 2 quarters · filed 2026-05-04 | $102.98M derived: sum of 3 quarters · filed 2026-05-04 | $134.77M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-12-31 | $36.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $68.94M derived: sum of 2 quarters · filed 2026-02-23 | $100.73M derived: sum of 3 quarters · filed 2026-08-03 | $129.37M 10-K · filed 2026-02-23 | ||
| 2025-09-30 | $32.22M 10-Q · filed 2025-10-28 | $64.01M derived: sum of 2 quarters · filed 2026-08-03 | $92.64M 10-Q · filed 2025-10-28 | $122.08M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-06-30 | $31.79M 10-Q · filed 2026-08-03 | $60.43M 10-Q · filed 2026-08-03 | $89.86M derived: sum of 3 quarters · filed 2026-08-03 | $118.91M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-03-31 | $28.64M 10-Q · filed 2026-05-04 | $58.07M derived: sum of 2 quarters · filed 2026-05-04 | $87.12M derived: sum of 3 quarters · filed 2026-05-04 | $114.68M derived: sum of 4 quarters · filed 2026-05-04 | ||
| 2024-12-31 | $29.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $58.48M derived: sum of 2 quarters · filed 2026-02-23 | $86.04M derived: sum of 3 quarters · filed 2026-02-23 | $111.05M 10-K · filed 2026-02-23 | ||
| 2024-09-30 | $29.05M 10-Q · filed 2025-10-28 | $56.61M derived: sum of 2 quarters · filed 2025-10-28 | $81.62M 10-Q · filed 2025-10-28 | $108.28M derived: sum of 4 quarters · filed 2026-02-23 | ||
| 2024-06-30 | $27.56M 10-Q · filed 2025-07-29 | $52.57M 10-Q · filed 2025-07-29 | $79.24M derived: sum of 3 quarters · filed 2026-02-23 | $107.28M derived: sum of 4 quarters · filed 2026-02-23 | ||
| 2024-03-31 | $25.01M 10-Q · filed 2025-04-30 | $51.67M derived: sum of 2 quarters · filed 2026-02-23 | $79.72M derived: sum of 3 quarters · filed 2026-02-23 | $109.67M derived: sum of 4 quarters · filed 2026-02-23 | ||
| 2023-12-31 | $26.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $54.71M derived: sum of 2 quarters · filed 2026-02-23 | $84.66M derived: sum of 3 quarters · filed 2026-02-23 | $112.56M 10-K · filed 2026-02-23 | ||
| 2023-09-30 | $28.04M 10-Q · filed 2024-10-29 | $57.99M derived: sum of 2 quarters · filed 2024-10-29 | $85.90M 10-Q · filed 2024-10-29 | $163.57M derived: sum of 4 quarters · filed 2024-10-29 | ||
| 2023-06-30 | $29.95M 10-Q · filed 2024-07-30 | $57.85M 10-Q · filed 2024-07-30 | $135.53M derived: sum of 3 quarters · filed 2024-07-30 | $205.21M derived: sum of 4 quarters · filed 2024-07-30 | ||
| 2023-03-31 | $27.90M 10-Q · filed 2024-04-29 | $105.58M derived: sum of 2 quarters · filed 2024-04-29 | $175.26M derived: sum of 3 quarters · filed 2024-04-29 | $241.03M derived: sum of 4 quarters · filed 2024-04-29 | ||
| 2022-12-31 | $77.68M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $147.36M derived: sum of 2 quarters · filed 2024-02-23 | $213.13M derived: sum of 3 quarters · filed 2024-02-23 | $261.44M 10-K · filed 2024-02-23 | ||
| 2022-09-30 | $69.69M 10-Q · filed 2023-11-03 | $135.45M derived: sum of 2 quarters · filed 2023-11-03 | $183.77M 10-Q · filed 2023-11-03 | $244.38M derived: sum of 4 quarters · filed 2023-11-03 | ||
| 2022-06-30 | $65.77M 10-Q · filed 2023-08-08 | $114.08M 10-Q · filed 2023-08-08 | $174.69M derived: sum of 3 quarters · filed 2023-08-08 | $226.18M derived: sum of 4 quarters · filed 2023-08-08 | ||
| 2022-03-31 | $48.32M 10-Q · filed 2023-05-09 | $108.92M derived: sum of 2 quarters · filed 2023-05-09 | $160.41M derived: sum of 3 quarters · filed 2023-05-09 | $208.59M derived: sum of 4 quarters · filed 2023-05-09 | ||
| 2021-12-31 | $60.61M 10-K · filed 2022-03-14 | $112.09M derived: sum of 2 quarters · filed 2022-11-14 | $160.27M derived: sum of 3 quarters · filed 2022-11-14 | $228.80M 10-K · filed 2023-03-16 | ||
| 2021-09-30 | $51.49M 10-Q · filed 2022-11-14 | $58.75M 10-Q · filed 2021-11-15 | $99.67M derived: sum of 2 quarters · filed 2022-11-14 | $168.19M 10-Q · filed 2022-11-14 | $180.19M 10-Q · filed 2021-11-15 | $237.82M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $48.18M 10-Q · filed 2022-08-15 | $116.70M 10-Q · filed 2022-08-15 | $186.33M derived: sum of 3 quarters · filed 2022-08-15 | $220.36M derived: sum of 4 quarters · filed 2022-08-15 | ||
| 2021-03-31 | $68.52M 10-Q · filed 2022-05-12 | $138.16M derived: sum of 2 quarters · filed 2022-05-12 | $172.18M derived: sum of 3 quarters · filed 2022-05-12 | $206.68M derived: sum of 4 quarters · filed 2022-05-12 | ||
| 2020-12-31 | $69.63M 10-K · filed 2022-03-14 | $103.65M derived: sum of 2 quarters · filed 2022-03-14 | $138.16M derived: sum of 3 quarters · filed 2022-03-14 | $175.30M 10-K · filed 2023-03-16 | ||
| 2020-09-30 | $34.02M 10-K · filed 2022-03-14 | $36.53M 10-Q · filed 2021-11-15 | $68.53M derived: sum of 2 quarters · filed 2022-03-14 | $111.75M 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | $34.51M 10-K · filed 2022-03-14 | $71.64M derived: sum of 2 quarters · filed 2022-03-14 | ||||
| 2020-03-31 | $37.14M 10-K · filed 2022-03-14 | |||||
| 2019-12-31 | $113.39M 10-K · filed 2022-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |